Recombinant Escherichia coli O8 Queuine tRNA-ribosyltransferase (tgt)

What is Queuine tRNA-ribosyltransferase (tgt) and what is its fundamental function?

Queuine tRNA-ribosyltransferase (tgt) is an enzyme responsible for catalyzing the exchange of guanine at position 34 (the wobble position) with queuine (q) in tRNAs containing GUN anticodons (tRNAHis, tRNAAsn, tRNAAsp, and tRNATyr). This modification produces queuosine (Q), a hypermodified nucleoside that plays a critical role in translational efficiency and accuracy . The enzyme functions by recognizing specific tRNA substrates, excising the guanine base from the wobble position, and inserting queuine in its place, thereby contributing to fine-tuning protein synthesis through enhanced codon-anticodon interactions .

How can researchers detect successful queuosine modification in tRNA?

Detection of Q-modified tRNAs can be performed using a Northern-based assay that exploits the differential migration of modified versus unmodified tRNAs on polyacrylamide gels containing 3-(acrylamido)phenylboronic acid (APB). In this methodology:

• tRNAs containing Q migrate more slowly on APB-containing gels than unmodified tRNAs

• After transfer to a nylon membrane, detection is achieved using a biotinylated probe specific for the target tRNA (e.g., tRNAAsp GUC)

• The presence of a higher band is indicative of Q-modified tRNAs, while lower bands represent unmodified tRNAs

This technique provides a reliable visual confirmation of tgt enzymatic activity and can be used to validate genetic complementation experiments or assess the substrate specificity of recombinant tgt variants.

What phenotypic changes occur in E. coli tgt deletion mutants?

E. coli strains lacking the tgt gene exhibit several distinct phenotypes that provide insights into the physiological roles of queuosine modification:

These pleiotropic effects demonstrate that queuosine modification influences multiple cellular processes beyond simple translational fidelity, particularly in metal and oxidative stress homeostasis .

How can the in vitro activity of recombinant E. coli tgt be measured using radioactive assays?

The activity of recombinant E. coli tgt can be precisely measured using a tRNA [14C] guanine displacement assay. This methodology involves:

• Pre-labeling of tRNA substrates:

  • Yeast tRNA is incubated with E. coli TGT and [8-14C] guanine-HCl

  • This creates radiolabeled tRNA with [14C] guanine at position 34

  • The labeled tRNA is extracted with acid phenol:chloroform and precipitated

• Displacement reaction:

  • Radiolabeled tRNA is incubated with recombinant tgt and test substrate (e.g., queuine)

  • If active, the enzyme will exchange the [14C] guanine with the test substrate

  • The displacement of radioactivity is measured to quantify enzyme activity

• Reaction conditions typically include:

  • 50 mM Tris-HCl, pH 7.5

  • 20 mM NaCl

  • 5 mM MgCl2

  • 2 mM dithiothreitol

  • 2 μg enzyme preparation

  • 200 μM substrate concentration

This assay allows for precise determination of enzyme kinetics and substrate preferences, making it valuable for characterizing mutant enzymes or testing potential inhibitors.

What strategies exist for heterologous expression of functional E. coli tgt?

Expression of catalytically active recombinant E. coli tgt requires careful consideration of several factors:

• Expression system selection:

  • BL21(DE3) tgt::Kmr cells are often preferred as they lack endogenous tgt activity

  • This prevents contamination with host enzyme and allows cleaner activity assessments

• Protein tagging approaches:

  • N-terminal polyhistidine tags facilitate purification without compromising activity

  • The tag placement should avoid interference with the active site

• Expression conditions optimization:

  • Induction at lower temperatures (16-25°C) often improves proper folding

  • Extended expression times (overnight) at reduced IPTG concentrations can increase soluble protein yield

• Activity validation:

  • Freshly purified enzyme maintains highest activity

  • Activity can be verified using radiolabeled guanine displacement assays

These strategies enable production of sufficient quantities of active enzyme for biochemical and structural studies.

How does E. coli tgt differ from human Queuine tRNA-Ribosyltransferase complex?

The functional and structural differences between bacterial and human queuine tRNA-ribosyltransferases have significant implications for research applications:

For experimental purposes, co-expression of human QTRT1 (N-terminal polyhistidine tagged) and QTRT2 (C-terminal SUMO-StrepII tagged) in BL21(DE3) tgt::Kmr cells produces a functional human enzyme complex that can be compared with E. coli tgt .

How does queuosine modification affect metal homeostasis in E. coli?

The absence of queuosine modification in E. coli leads to significant alterations in metal homeostasis:

• Transcriptomic evidence:

  • In Q-deficient strains, nickel transporter genes (nikABCDE) are downregulated even in the absence of nickel stress

  • This "priming" effect explains the heightened resistance to nickel toxicity

• Resistance mechanisms:

  • Q-deficient mutants show improved growth in the presence of nickel (2 mM) and cobalt (0.85 mM)

  • Doubling times decrease from 5.3h in wild-type to 4h in Δtgt strains under nickel stress

• Metal sensitivity shifts:

  • While resistance to nickel and cobalt increases, sensitivity to cadmium is enhanced

  • This suggests a complex rewiring of metal homeostasis networks rather than general metal resistance

• Evolutionary implications:

  • TnSeq fitness studies confirmed that insertions in tgt, queA, and queG genes provided growth advantages under nickel and cobalt stress

  • This suggests the Q modification may have evolved partly to help regulate metal homeostasis

These findings reveal an unexpected link between tRNA modification and metal ion handling in bacteria, opening new research directions for understanding translation-metabolism connections.

What is the relationship between E. coli tgt activity and oxidative stress response?

Research has revealed a complex interplay between queuosine modification and oxidative stress management in E. coli:

• Experimental evidence for increased oxidative stress in Q-deficient strains:

  • Elevated reactive oxygen species (ROS) levels detected in Δtgt mutants

  • Increased sensitivity to hydrogen peroxide and paraquat (oxidative stress inducers)

  • Subtle growth phenotype in strains prone to ROS accumulation

• Transcriptomic insights:

  • Analysis of Q-deficient strains revealed an atypical oxidative stress response signature

  • Changes in expression of genes controlled by Fe-S cluster-containing regulators

  • Altered activity of promoters regulated by oxidative stress (PiscR, PhmpA, PydfZ)

• Physiological consequences:

  • The link between Q modification and oxidative stress suggests translational control of redox balance

  • This may explain some of the pleiotropic phenotypes observed in Q-deficient strains

  • Potential implications for adaptation to environments with varying oxygen availability

These findings suggest that tgt activity influences how cells manage oxidative stress, possibly through translational regulation of key redox proteins.

What novel applications of E. coli tgt are emerging in therapeutic research?

Recent research has identified potential therapeutic applications based on manipulating queuosine modification pathways:

• Cardiovascular disease applications:

  • Inhibition of queuine tRNA-ribosyltransferase 1 (QTRT1) significantly attenuates hyperlipidemia and atherosclerosis in mouse models

  • QTRT1 deficiency in hepatocytes leads to:

    • Reduced de novo lipogenesis (DNL)

    • Decreased liver steatosis

    • Reduced atherosclerotic burden

    • Increased plaque stability in the aorta

• Molecular mechanisms:

  • Depletion of QTRT1 downregulates lipogenic pathways without affecting lipoprotein transportation or fatty acid oxidation

  • RNA-seq analysis identified upregulation of odorant binding protein 2A (OBP2A) in QTRT1-deficient hepatocytes

  • OBP2A appears to counteract the promotion of DNL by QTRT1

• Therapeutic potential:

  • Targeting QTRT1 represents a promising strategy for treating both hyperlipidemia and atherosclerosis

  • This approach addresses multiple aspects of metabolic dysfunction simultaneously

These findings suggest that understanding bacterial tgt could provide insights for developing novel cardiovascular therapies targeting the human QTRT1/QTRT2 complex.

How can researchers utilize recombinant E. coli tgt for studying novel tRNA modifications?

Recombinant E. coli tgt serves as a valuable tool for investigating tRNA modifications beyond its natural substrate:

• Artificial nucleobase incorporation:

  • E. coli tgt can be exploited to incorporate artificial nucleobases into tRNA

  • This allows for structure-function studies of modified tRNAs

  • The displacement assay can be adapted to screen acceptance of non-natural substrates

• Experimental approach:

  • Pre-charged tRNA with [14C] guanine is incubated with tgt and test compounds

  • Displacement of the radiolabel indicates successful incorporation of the test substrate

  • This system allows rapid screening of potential substrates for incorporation

• Applications in synthetic biology:

  • Creating tRNAs with novel properties for expanded genetic code applications

  • Studying translation effects of artificial modifications

  • Developing orthogonal translation systems

This versatility makes recombinant E. coli tgt an important enzyme for both fundamental research and biotechnological applications in RNA modification engineering.

What bacterial queuine salvage pathways have been recently discovered?

Recent research has identified previously unknown bacterial queuine salvage pathways with significant implications for host-microbe interactions:

• Discovery of queuine salvage enzymes:

  • Comparative genomics has revealed that many bacteria, including pathogens and host-associated organisms, possess pathways to salvage queuine

  • This suggests direct competition for queuine precursors in the human gut microbiome

• Key components identified:

  • YhhQ transporters in various bacteria function as queuine transporters

  • These transporters allow bacteria to take up queuine from the environment

  • The presence of these transporters correlates with the ability to use exogenous queuine

• Experimental validation:

  • Expression of Chlamydia trachomatis YhhQ homolog (YhhQ Ct) and TGT homolog (TGT Ct) in E. coli Δqueuine mutants restored Q modification when exogenous queuine was provided

  • This confirms that these genes encode functional queuine transport and incorporation systems

These findings reveal that queuine acquisition represents an important aspect of host-microbe nutrient competition, with potential implications for human health.

What methodological approaches are recommended for genetic complementation studies with E. coli tgt?

When conducting genetic complementation studies with tgt genes, researchers should consider the following methodological recommendations:

• Construction of clean deletion strains:

  • Create markerless deletion strains (e.g., ΔqueD strain with no antibiotic resistance cassette)

  • Use Flp-catalyzed excision to remove resistance markers when constructing multiple deletion strains

  • Create appropriate control strains (e.g., Δyhhqq ΔqueD Δtgt)

• Expression system considerations:

  • Use inducible promoters with tunable expression levels

  • Ensure appropriate codon usage for heterologous tgt genes

  • Consider protein tagging strategies that don't interfere with function

• Validation approaches:

  • Northern blot analysis with APB gels to detect Q-modified tRNAs

  • Growth complementation assays under metal stress conditions

  • Measurement of reporter gene expression for affected pathways

• Controls and verification:

  • Include wild-type and deletion mutants as controls

  • Test complementation with known substrates and precursors (preQ0, preQ1, q)

  • Verify protein expression by Western blot

Following these approaches ensures robust and reproducible results when studying the functional aspects of tgt genes from different organisms.

How can researchers overcome expression and solubility issues with recombinant E. coli tgt?

When facing challenges with expression and solubility of recombinant E. coli tgt, researchers should consider these strategies:

• Expression optimization:

  • Lower induction temperature (16-20°C) significantly improves solubility

  • Reduce IPTG concentration to 0.1-0.5 mM and extend expression time

  • Use specialized E. coli strains like Rosetta or ArcticExpress for problematic constructs

• Solubility enhancement:

  • Include solubility-enhancing fusion partners (SUMO, MBP, or thioredoxin)

  • Optimize buffer conditions during lysis and purification:

    • Include 5-10% glycerol to stabilize protein structure

    • Test various salt concentrations (150-500 mM NaCl)

    • Add reducing agents (1-5 mM DTT or β-mercaptoethanol)

• Co-expression strategies:

  • Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ)

  • For human QTRT1/QTRT2 complex, ensure balanced expression of both subunits

• Purification considerations:

  • Use affinity purification followed by ion exchange and size exclusion chromatography

  • Maintain enzyme at 4°C throughout purification to preserve activity

  • Avoid freeze-thaw cycles which can dramatically reduce enzyme activity

These approaches have been shown to significantly improve yields of active recombinant tgt enzyme for biochemical and structural studies.

What are the critical factors affecting the reproducibility of tgt activity assays?

To ensure reproducible results in tgt activity assays, researchers should carefully control these critical factors:

• Enzyme preparation quality:

  • Fresh enzyme preparations consistently show higher activity

  • Standardize protein concentration measurements using BCA or Bradford assays

  • Verify enzyme purity by SDS-PAGE (>90% homogeneity recommended)

• Substrate considerations:

  • Use high-purity tRNA substrates (commercially available yeast tRNA often varies between lots)

  • For radioactive assays, ensure [14C] guanine has high specific activity

  • Store nucleobase substrates protected from light at -20°C in small aliquots

• Reaction conditions standardization:

  • Maintain consistent:

    • pH (7.5 is optimal for E. coli tgt)

    • Temperature (37°C standard)

    • Incubation times (2 hours for pre-labeling, 15-60 minutes for displacement)

    • Buffer composition (50 mM Tris-HCl, 20 mM NaCl, 5 mM MgCl2, 2 mM DTT)

  • Include positive controls (known substrates) and negative controls (heat-inactivated enzyme)

• Data analysis considerations:

  • Use appropriate statistical methods for replicate analysis

  • Report activity as percentage of displacement relative to maximum (guanine) control

  • Consider enzyme kinetics (Km, Vmax) for comprehensive characterization

Attention to these factors will significantly improve the reliability and comparability of results between different experiments and laboratories.